S J Clark1, J Harrison, P L Molloy
1Kanematsu Laboratories, Royal Prince Alfred Hospital, Camperdown, Australia. clark@pelican.dbe.csiro.au
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Methylation of CpCpG sites, but not CpG sites, inhibits Sp1 transcription factor binding. This finding, observed in retinoblastoma tumors, suggests a role for CpCpG methylation in cancer development.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: